FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...

In today's ACT Brief, we recap key themes from DIA 2026 on operational priorities and regulatory shifts, examine ...

Microsoft 365 Copilot deployment aims to automate high-volume, repeatable work, freeing clinical operations staff for ...

In this video interview following the 2026 DIA Global Annual Meeting, Jonathan Andrus, co-CEO of CRIO, explains why ...

Clinical trial sponsors are navigating a shifting landscape that includes both long-established life sciences companies ...

This article argues that improving financial outcomes—including more reliable revenue recognition—requires revisiting the ...

In this video interview, Marwan Fathallah, president and CEO of DIA Global, shares the key trends and themes shaping this ...

In today's ACT Brief, we examine regulatory uncertainty and 2026 breakthroughs shaping clinical research, reimagining CRO ...

In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...

In this video interview from the 2026 DIA Global Annual Meeting, Joan Chambers, independent senior consultant at Tufts CSDD, ...

Insilico Medicine and SK Biopharmaceuticals entered an R&D collaboration on AI-enabled drug discovery in neuroimmune CNS ...

In today's ACT Brief, we examine real-time evidence generation priorities, automating protocol digitization, and ...